Wiley and the British Society for Nanomedicine launch new OA publication, the Journal of Interdisciplinary Nanomedicine - 06 Jul 2015
Publisher John Wiley and Sons, Inc., and the British Society for Nanomedicine have announced the launch of a new open access publication, the Journal of Interdisciplinary Nanomedicine.
The Journal of Interdisciplinary Nanomedicine (JOIN) is an international, peer-reviewed journal that aims to provide truly interdisciplinary nanomedicine research. JOIN will contain evidence-based outputs with high-level contributions from at least two sciences and embraces submissions from all relevant fields.
The journal joins Wiley's portfolio of nanotechnology journals with the support of many respected titles, including: Advanced Materials, Advanced Functional Materials, Advanced Healthcare Materials, Macromolecular Bioscience, and Small. JOIN is one of the first open access journals to offer interdisciplinary research specific to nanomedicine.
Andrew Owen, a Professor of Pharmacology at the University of Liverpool, serves as the co-editor-in-chief for JOIN. He is also Chair of the British Society for Nanomedicine and a fellow of the Society of Biology. Andrew's recent research focuses on addressing translational barriers for various nanotechnologies being applied to treatment of infectious diseases. The journal has been co-founded with Professor Steve Rannard (University of Liverpool, UK), Professor Si-Shen Feng (National University of Singapore, Singapore and The Second Military Medical University, China) and Dr Raj Bawa (Rensselaer Polytechnic Institute, Troy, New York and Bawa Biotech LLC, Ashburn, VA).
All articles in JOIN will be published under the Creative Commons Attribution (CC-BY) License on Wiley Online Library. Authors with open access mandates from funders will be fully compliant when publishing with this journal. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organisation that has a Wiley Open Access Account can publish without directly paying any publication charges.
The journal is open to submissions now and plans to publish the first issue online in Fall 2015.
New Adis platform, AdisInsight, provides window into current evidence on research into new drug treatments - 06 Jul 2015
Adis, a global provider of drug information, has taken a major step forward in its quest to make expertly written drug information more accessible, with the launch of a new platform AdisInsight. The platform presents a unique, joined-up view of current evidence on drug treatments being developed worldwide – how well they work, how safe they are, who is working on them, and how soon they will be available – in a single database.
All of the content in the platform is created as a result of a rigorous curation process undertaken by a team of scientific editors. Multiple global sources including journals, conference proceedings, and government and company websites are monitored continuously to identify any potentially relevant new data. Information is then assessed and verified before being consolidated into concise narratives.
For more than 40 years, Adis has been supporting its users through its portfolio of drug-focused medical journals and business intelligence solutions. AdisInsight brings together content from three well-established Adis databases: R&D Insight, Clinical Trials Insight and Pharmacovigilance Insight. The AdisInsight platform is currently available to preview at adisinsight.springer.com
SAGE partners with SingHealth to publish SingHealth’s flagship journal, Proceedings of Singapore Healthcare - 06 Jul 2015
Academic publisher SAGE and SingHealth have announced a new partnership to publish SingHealth's flagship journal, Proceedings of Singapore Healthcare, effective September 2015. The journal will remain owned by SingHealth but will be published by SAGE.
Proceedings of Singapore Healthcare is an international, peer-reviewed journal that publishes quality research on all aspects of healthcare and biomedical sciences, with an emphasis on research of direct clinical relevance. The journal aims to improve the quality of care to patients by informing and stimulating discussion among health professionals. The journal's geographic focus on healthcare and biomedical research enables it to provide a unique insight into a specialist area of research within Southeast Asia; however, the editors encourage contributions from all parts of the globe.
Published quarterly as an open access (OA) journal, the journal is free for authors to publish in and papers will be published with a CC-BY-NC license.
BioMed Central journals see growth in impact factor - 06 Jul 2015
A total of 175 journals in BioMed Central's publishing portfolio now have impact factors in the recently published Journal Citation Report 2015, of which 104 journals rank in the top half of their categories.
Nine journals received their first impact factor. Biology of Sex Differences gained an impact factor of 4.84, placing it in the top quartile of both of its categories of Endocrinology & Metabolism and Genetics & Heredity. Infectious Diseases of Poverty received an impact factor of 4.11, placing it in the top quartile of the Infectious Diseases category.
Molecular Neurodegeneration is now the highest ranking open access journal in the Neurosciences category, with an impact factor of 6.56, and overall is one of the highest ranked journals dedicated to neurodegeneration research.
BioMed Central's flagship journals have also seen increases in their impact factors over the last year. Genome Biology now has an impact factor of 10.81. This makes it seventh out of all 167 journals in the Genetics & Heredity category and the highest ranking open access journal in both of its categories. It is also the highest ranking open access journal in the Biotechnology and Applied Microbiology category according to its Eigenfactor - a measure which takes into account how often the journal is cited in a highly-cited journal.
BMC Biology's impact factor has grown to 7.98, making it fourth out of 85 journals in the Biology category. BMC Medicine is the second highest ranking open access journal in the Medicine, General & Internal category, with an impact factor of 7.25, and ranks 10 out of 153 journals in that category overall. The journal has also had articles with an Altmetric score of over 900 – a measure that takes into account an article's impact in terms of news coverage and social media.
Since transferring to BioMed Central in 2008, the Journal of Experimental & Clinical Cancer Research has seen its impact factor rise each year to a current high of 4.43. This places it in the top quartile of the Oncology category.
Genetics Selection Evolution is the highest ranking journal in the Agriculture, Dairy & Animal Science category, with an impact factor of 3.82. The society journal, owned by the French government agency for agriculture, has seen continuous growth in its impact factor since it transferred to BioMed Central in 2009.
Overleaf and Bookmetrix announced as finalists in the ALPSP Awards for Innovation in Publishing 2015 - 06 Jul 2015
Overleaf and Bookmetrix, the joint project between Altmetric and Springer, have both been announced as finalists in the ALPSP Awards for Innovation in Publishing 2015.
The ALPSP awards are open to any new development, product, service, launch or project which is both innovative and of significant value to the scholarly communication arena. In order to win finalists must demonstrate excellence in terms of originality and innovation, significance and value to the community, utility and long-term viability.
Overleaf is the new collaborative writing and publishing system from the team behind writeLaTeX. Bookmetrix is essentially 'altmetrics for books' and has been rolled out across Springer's entire library, offering authors and publishers new insights into how their books are being discussed, cited, and used.
The finalists will be given the opportunity to showcase their products in a rapid fire session at the ALPSP Conference on September 9. The winners will then be announced at the Conference Awards Dinner on Thursday 10 September.
Brazil’s Hospital Metropolitano Sul Dom Helder Câmara opts for UpToDate Anywhere clinical decision support - 06 Jul 2015
Wolters Kluwer, a global provider of information and point of care solutions for the healthcare industry, has announced that the Hospital Metropolitano Sul Dom Helder Câmara (HDH) in Brazil is launching UpToDate® Anywhere mobile clinical decision support on the occasion of the hospital's fifth anniversary.
UpToDate will be used to improve the quality of care provided by HDH, and will also support the professional development of future clinicians as part of the hospital's medical residency, nursing and physical therapy programs. With mobile access to the clinical decision support resource at the hospital or any other location, residents can use UpToDate to care for patients and review the latest clinical studies.
The hospital, based in the city of Cabo de Santo Agostinho, has more than 1,000 healthcare staff. HDH is recognized in the region for extensive emergency care, including cardiology as well as orthopaedic trauma, general surgery and internal medicine. In addition to 24 emergency care beds, the hospital has 145 in-patient beds for the specialties above, as well as an intensive care unit covering general care, coronary care, cardiac surgery recovery and hemodynamics.
HDH sought to provide their doctors with the best diagnostic and treatment recommendations at the point of care, whether at the patient bedside, consultation room, or off-site. By selecting UpToDate Anywhere, clinicians have anytime/anywhere access, via their mobile devices, to the acclaimed clinical decision support resource, used by over 1 million clinicians in more than 170 countries. More than 60 research studies confirm UpToDate's widespread usage and association with quality metrics such as improved patient care and hospital performance, including reduced length of stay, adverse complications and mortality.
In the future, HDH plans to make UpToDate accessible within their electronic health record, making it even easier for clinicians to find answers to clinical questions while caring for patients. In addition, thanks to the patented Search In Your Own Language feature, searches in UpToDate can also be performed in Portuguese.
SHERPA/FACT found to be over 95 percent accurate when checking publisher policies against funder mandates for open access - 06 Jul 2015
SHERPA/FACT, the funders and author's compliance tool, has been found to be more than 95 percent accurate when checking publisher policies against funder mandates for open access – significantly higher than even experienced repository managers.
A study by the SHERPA/FACT advisory group compared the information provided by SHERPA/FACT with a control made up of members of UKCoRR (United Kingdom Council of Research Repositories), who manually checked the policies.
Where a discrepancy was identified between the two sets of data, the advisory group made an investigation into which returned the correct result, and found that SHERPA/FACT was correct in almost all of the cases, against 57 percent of the time for human checking.
For researchers, this should come as clear evidence that SHERPA/FACT can provide accurate results on journal and funder policy alignment on open access, better enabling them to decide where to publish their research outputs to meet funder requirements.
The study was commissioned by the SHERPA/FACT Advisory Board – which includes representatives from UKCoRR, Jisc, Wellcome Trust, Research Councils UK (RCUK), CRC Nottingham, Association of Learned and Professional Society Publishers (ALPSP), Higher Education Funding Council for England (HEFCE), Publishers Association and SCONUL.
SHERPA/FACT works by syndicating information on journal policies on open access and reviewing this against the funding requirements of RCUK and Wellcome Trust. It draws this information from the SHERPA/RoMEO and SHERPA/JULIET databases respectively.
Funded by RCUK, Wellcome Trust and Jisc, SHERPA/FACT is developed and maintained by the Centre for Research Communications (CRC) at the University of Nottingham.
Emerald Group Publishing and Portico extend relationship to preserve e-books - 06 Jul 2015
Academic publisher Emerald Group Publishing is extending its relationship with Portico to preserve its e-books in the Portico archive. With this move, Emerald seeks to ensure that their e-book content will be secure and available into the future.
Established in 1967, Emerald Group Publishing Limited manages a portfolio of over 290 journals and over 2,500 books and book series volumes. It also provides an extensive range of value-added products, resources, and services to support its customers' needs.
Emerald has been preserving its e-journals with Portico since 2009.
Latest edition of Blogspeak now online - 06 Jul 2015
The latest edition of Blogspeak is now online. Featured are: Kevin L. Smith (Does the Copyright Office Belong in a Library? | Peer to Peer Review); Phill Jones (What Do You Hear When You Buy a Researcher a Beer? Frustration!); Lettie Conrad (Guest Post: Lettie Conrad on Metadata Promiscuity and the Researcher Experience); Cameron Neylon (Academic freedom and authority are fundamentally about responsibilities and public scholars must navigate with care); and Randy Silverman (Guest Book Review: Disaster Planning for Libraries: Process and Guidelines). Blogspeak includes blog posts relevant to the publishing industry, particularly STM publishing. Subscribers are invited to participate in the latest edition of Blogspeak Here.